atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference

Group 1 - atai Life Sciences is a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders [1][2] - The company will participate in a panel discussion at the TD Cowen conference in Boston on March 4, 2024, at 12:50pm ET [1] - A live audio webcast of the panel discussion will be available on the company's website, with a replay accessible after the event [1] Group 2 - atai aims to pool resources and best practices to accelerate the development of new medicines for mental health [2] - The company's vision is to heal mental health disorders, enabling individuals to live more fulfilled lives [2]